Prescient broadens its footprint in Europe with the opening of locations in Munich and Madrid.

LONDON, November 2, 2021 — Prescient®, a biopharma product and portfolio strategy firm, announces the expansion of its global footprint with new locations in Munich and Madrid. By extending our global footprint to include mainland Europe, Prescient is now even better positioned to attract top talent and service our biopharma clients, be they European-headquartered companies or regional affiliates.

“Munich is an obvious location for our EU hub,” says Jamie Denison-Pender, CEO. “German-speaking Europe houses the global and regional headquarters of many of the biggest and most innovative biopharmaceutical companies, many of which are our clients. Munich will allow us to develop stronger relationships and deliver an enhanced client experience. Munich also offers access to a hotbed of scientific, medical and consultancy talent – all critical to delivering exceptionally high quality and sustaining our rapid growth. In addition to building a team of German-speaking colleagues, Munich will represent an opportunity for top talent to join us from across Europe.”

Denison-Pender continues, “Spain has always been a rich source of high-quality scientific and strategic talent. Prior to Brexit, we benefited enormously as Spaniards relocated to London to pursue careers in pharma, pharma services and consultancy. With this now being slightly more challenging, it was an easy decision for us to expand our footprint to include Madrid.”